Published online ahead of print July 26, 2010
CMAJ 10.1503/cmaj.100105
© 2010 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Online Appendix
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Sood, M. M.
Right arrow Articles by Rigatto, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sood, M. M.
Right arrow Articles by Rigatto, C.

Original Article

Adverse outcomes among Aboriginal patients receiving peritoneal dialysis

Manish M. Sood 1, Paul Komenda 2, Amy R. Sood 3, Martina Reslerova 2, Mauro Verrelli 2, Chris Sathianathan 2, Loretta Eng 2, Amanda Eng 2, Claudio Rigatto 4

1 The Department of Medicine, St. Boniface Hospital, University of Manitoba, Winnipeg, Man.
2 The Department of Nephrology, St. Boniface Hospital, University of Manitoba, Winnipeg, Man.
3 The Department of Pharmacy, St. Boniface Hospital, University of Manitoba, Winnipeg, Man.
4 The Department of Internal Medicine, University of Manitoba, Winnipeg, Man.


*   Abstract

Background: The Aboriginal population in Canada experiences high rates of end-stage renal disease and need for dialytic therapies. Our objective was to examine rates of mortality, technique failure and peritonitis among adult aboriginal patients receiving peritoneal dialysis in the province of Manitoba. We also aimed to explore whether differences in these rates may be accounted for by location of residence (i.e., urban versus rural).

Methods: We included all adult patients residing in the province of Manitoba who received peritoneal dialysis during the period from 1997–2007 (n = 727). We extracted data from a local administrative database and from the Canadian Organ Replacement Registry and the Peritonitis Organism Exit-sites/Tunnel infections (POET) database. We used Cox and logistic regression models to determine the relationship between outcomes and Aboriginal ethnicity. We performed Kaplan–Meier analyses to examine the relationship between outcomes and urban (i.e., 50 km or less from the primary dialysis centre in Winnipeg) versus rural (i.e., more than 50 km from the centre) residency among patients who were aboriginal.

Results: One hundred sixty-one Aboriginal and 566 non-Aboriginal patients were included in the analyses. Adjusted hazard ratios for mortality (HR 1.476, CI 1.073–2.030) and adjusted time to peritonitis (HR 1.785, CI 1.352–2.357) were significantly higher among Aboriginal patients than among non-Aboriginal patients. We found no significant differences in mortality, technique failure or peritonitis between urban- or rural-residing Aboriginal patients.

Interpretation: Compared with non-Aboriginal patients receiving peritoneal dialysis, Aboriginal patients receiving peritoneal dialysis had higher mortality and faster time to peritonitis independent of comorbidities and demographic characteristics. This effect was not influenced by place of residence, whether rural or urban.